Pentoxifylline and vitamin E treatment for prevention of radiation induced side effects in women with breast cancer

Completed

• Conditions: Breast cancer; Cancer; Malignant neoplasm of the breast

• Registration Number: ISRCTN39143623
• Lead Sponsor: und University Hospital (Sweden)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-10-30
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

1. Women (no age limit) with breast cancer
2. Treated with axillary dissection, mastectomy or segmental resection of the breast, and radiotherapy to the breast and axilla
3. All active cancer treatment is terminated, except for anti-hormone treatment with tamoxifen, letrozol, anastrozole, and exemestane
4. Able to understand the nature of the trial and give written informed consent

Exclusion Criteria

1. Known sensitivity to pentoxifylline or vitamin E
2. Disorders related to muscles or joints
3. Corticosteroid treatment during radiotherapy treatment

Study & Design

• Study Type: Interventional
• Study Design: Not specified